{"nctId":"NCT00723606","briefTitle":"A Randomized, Open-Label, Multi-Center Study To Evaluate The Efficacy And Safety Of Intramuscular Ziprasidone In Patients With Agitation","startDateStruct":{"date":"2008-09"},"conditions":["Schizophrenia"],"count":376,"armGroups":[{"label":"Intramuscular ziprasidone","type":"EXPERIMENTAL","interventionNames":["Drug: Intramuscular ziprasidone mesylate"]},{"label":"Intramuscular haloperidol","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Intramuscular haloperidol"]}],"interventions":[{"name":"Intramuscular ziprasidone mesylate","otherNames":["Zeldox, Geodon"]},{"name":"Intramuscular haloperidol","otherNames":["Haldol"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Male or female Chinese subjects aged 18-65 years (including 65) at screening.\n* Subjects meeting the ICD-10 (Classification of Mental and Behavioral Disorders) criteria for schizophrenia (F20.X).\n* Subjects who are in acute phase of schizophrenia and are appropriate to receive intramuscular medication for at least 3 days\n\nExclusion Criteria:\n\n* History of clinically significant physical illness especially myocardial infarction, non compensatory heart failure etc.\n* Subjects receiving an investigational agent in the previous 3 months prior to screening.\n* Use of antipsychotic agents within 12 hours or parenteral benzodiazepines within 4 hours prior to randomization and during the study.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"65 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline in Brief Psychiatric Rating Scale (BPRS) Total Scores at 72 Hours","description":"BPRS is an 18-item clinician rated scale with 11 general symptom items, 5 positive-symptom items, and 2 negative symptom items scored on a 7-point scale (1=not present and 7=extremely severe), with higher score indicating greater severity of symptom. Total possible score range=18 to 126. Change: score at final visit minus score at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-17.32","spread":"0.692"},{"groupId":"OG001","value":"-18.44","spread":"0.720"}]}]}]},{"type":"SECONDARY","title":"BPRS Agitation Subscale Response at 72 Hours","description":"The BPRS agitation subscale score was composed of 4 questions (questions 2, 6, 10, 17). The BPRS agitation subscale score was obtained by summing the relevant individual items. Total possible score range=4 to 28. A response was defined as a \\> 30 percent reduction from baseline in BPRS agitation subscale score.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"149","spread":null},{"groupId":"OG001","value":"155","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"39","spread":null},{"groupId":"OG001","value":"29","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in BPRS Agitation Subscale Score at 72 Hours","description":"The BPRS agitation subscale score was composed of 4 questions (questions 2, 6, 10, 17). The BPRS agitation subscale score was obtained by summing the relevant individual items. Total possible score range=4 to 28. Change: score at final visit minus score at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.97","spread":"0.225"},{"groupId":"OG001","value":"-7.45","spread":"0.228"}]}]}]},{"type":"SECONDARY","title":"Clinical Global Impression-Improvement (CGI-I) Score at 72 Hours","description":"CGI-I: 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement is defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale. Higher score = more affected.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.52","spread":"0.056"},{"groupId":"OG001","value":"2.55","spread":"0.057"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Clinical Global Impressions Severity (CGI-S) Score at 72 Hours","description":"CGI-S: 7-point clinician rated scale to assess severity of subject's current illness state; range: 1 (normal - not ill at all) to 7 (among the most extremely ill patients). Higher score = more affected. Change: score at observation minus score at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.18","spread":"0.061"},{"groupId":"OG001","value":"-1.21","spread":"0.062"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Behavioral Activity Rating Scale (BARS) at 72 Hours","description":"BARS measures the degree of agitated behavior using a 7-point scale describing increasing levels of activity (1 =difficult or unable to rouse; 2 = asleep but responds normally to verbal or physical contact; 3 = drowsy, appears sedated; 4 = quiet and awake \\[normal level of activity\\]; 5 = signs of overt \\[physical or verbal\\] activity, calms down with instructions; 6 = extremely or continuously active, not requiring restraint; 7 = violent, requires restraint.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.93","spread":"0.044"},{"groupId":"OG001","value":"-1.06","spread":"0.044"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":189},"commonTop":["Extrapyramidal disorder","Somnolence","Akathisia","Dizziness","Insomnia"]}}}